Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Their first buy on recordTraded May 22 · filed 4 days later
Since the trade +25.6% · S&P 500 −7.5% · to Nov 20
Bought 27% below the 52-week high, RSI 48, 15% under its 200-day average, 33 points behind the S&P 500 over 3 months
A GE HealthCare director paid $642K out of pocket for GE HealthCare shares. 7 other people at GE HealthCare bought some too, in the same month. Shares held went up 229% with this purchase.
A GE HealthCare director paid $63K out of pocket for GE HealthCare shares. 7 other people at GE HealthCare bought some too, in the same month. Shares held went up 8% with this purchase.
A GE HealthCare director paid $5M out of pocket for GE HealthCare shares. 7 other people at GE HealthCare bought some too, in the same month. Shares held went up 115% with this purchase.
A GE HealthCare director paid $62K out of pocket for GE HealthCare shares. 7 other people at GE HealthCare bought some too, in the same month. Shares held went up 7% with this purchase.
GE HealthCare's GC & Corporate Secretary paid $106K out of pocket for GE HealthCare shares. 7 other people at GE HealthCare bought some too, in the same month.
8 open-market purchases and 0 open-market sales by insiders of GEHC between Jan 5, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Oct 28, 2026. The data provider lists the next release for Feb 8, 2027; that date may change.
PurchaseSale30 days before a release30 days after
Trades in the 30 days around each of the last earnings releases
Kevin Lobo, Director, May 22, 2026, about $642K. Bought 23 days after the company's previous earnings release on 2026-04-29Form 4
Rodney F Hochman, Director, May 12, 2026, about $100K. Bought 13 days after the company's previous earnings release on 2026-04-29Form 4
Watkin Phoebe L. Yang, Director, May 8, 2026, about $63K. Bought 9 days after the company's previous earnings release on 2026-04-29Form 4
H Lawrence Jr Culp, Director, May 6, 2026, about $5M. Bought 7 days after the company's previous earnings release on 2026-04-29Form 4
, Director, May 6, 2026, about $62K. Bought 7 days after the company's previous earnings release on 2026-04-29
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies